报价延迟最少15分钟:2026/02/28 17:09 EST
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
1.23 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-0.45/-0.41
|
|
企业价值
119.47M
|
| 资产负债 |
|
每股账面净值
0.02
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
0
|
|
每股收益
--
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| Vivani Medical Inc is a clinical-stage biopharmaceutical company whose primary focus is the development of miniature subdermal drug implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases with once or twice-yearly administration. Its flagship drug implant candidates are designed to improve medication adherence and provide smooth, consistent therapeutic levels of GLP-1, the same class of active pharmaceutical ingredients used in Ozempic, Trulicity, and Wegovy. |
